Rho Ventures — 2016 Investments

4 investments dated 2016 · listed companies and verified rows first · show all

Dashlanedashlane.com in 𝕏Apr 2016

Dashlane provides a credential security platform that unifies password management and credential protection for businesses.

CybersecurityEnterprise SoftwareSaaSNew York, US

Emmanuel Schalit(Executive Officer, Director)

BoardBernard Liautaud(Director)inAlex Ferrara(Director)inRick Heitzmann(Director)inJohn Danaher(Director)

Board seatHabib Kairouz· per SEC Form D

Co-investorsBessemer Venture Partners FirstMark Capital Rho Capital Partners Sequoia Capital Balderton Capital

Host CommitteeApr 2016SEC filingmedium confidence

New York, US

Vanessa Liu(Executive Officer, Director)

BoardAndrew Russell(Director)

Board seatJeff Grammer· per SEC Form D · $8.8M raise · filed Jan 2017

Rocketriprocketrip.com inJun 2016acquired by Mondee (now Tabhi)SEC filingmedium confidence

AI & Machine LearningEnterprise SoftwareFintechMarketplacesTravel & HospitalityNew York City, US

Prasad Gundumogula(Founder, Group Chairman & CEO)Daniel Ruch(Executive Officer, Director)inGillian Tee(Director)Orestes Fintiklis(Executive Vice Chairman)Jesus Portillo(CEO of Latin America)Trevor Vigfusson(Chief Financial Officer)

Board seatHabib Kairouz· per SEC Form D · $9M raise · filed Jun 2016

Co-investorsMorgan Stanley Canaan Partners Comcast Ventures GV (Google Ventures)Y Combinator Bessemer Venture Partners +1 more

Mersanamersana.com in 𝕏Jun 2016

A biopharmaceutical company developing targeted oncology medicines, with a focus on treatments for patients of all ages including children with cancers such as pediatric low-grade glioma (pLGG).

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

MICHAEL J. KAUFMAN(Executive Officer)DONALD BERGSTROM(Executive Officer)ANNA PROTOPAPAS(Executive Officer, Director)DAVID MOTT(Director)TIMOTHY LOWINGER(Executive Officer)EVA JACK(Executive Officer)

Co-investorsBain Capital Life Sciences F-Prime Capital Lightstone Ventures New Enterprise Associates (NEA)Nextech Invest Pfizer Venture Investments

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.